Parkinson’s disease (PD), or simply Parkinson’s, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognitio.
VLA COMMENT: If the Covid Vaccine is linked to Parkinson and Dementia, think of all the childhood vaccines with mercury and aluminum. As well, vaccines damage the mitochondria. A study I once read authored by some head Doctor at a big medical University suggests that his work shows that all mentally ill people have damaged mitochondria. Which came first, the chicken or the egg>
Historical Context and Uses
Originally developed by Merck & Co. in the late 1970s, Ivermectin was first used as a veterinary drug against worms in animals. In humans, its primary utility has been in the treatment of diseases caused by parasitic worms, like onchocerciasis (river blindness) and lymphatic filariasis. Due to its efficacy against these diseases, the World Health Organization (WHO) has listed Ivermectin on its list of essential medicines.
The Pioneers Behind Ivermectin:
The development of Ivermectin was not just a monumental leap in the field of medicine; it was also a testament to the perseverance and innovation of two eminent scientists – Dr. William C. Campbell and Professor Satoshi Ōmura.
Satoshi Ōmura: A distinguished Japanese microbiologist and bioorganic chemist, Professor Ōmura’s work primarily focused on isolating naturally occurring microbes from the soil. His belief in the potential therapeutic applications of these microbes led him to identify and cultivate a unique strain of bacteria called *Streptomyces avermitilis*. This strain proved to be the foundation for the creation of Ivermectin.
William C. Campbell: An Irish-born biologist, Dr. Campbell’s insights into the realm of parasitic diseases were pivotal. Working with Merck Institute for Therapeutic Research, Campbell identified the antiparasitic properties of the compounds derived from Professor Ōmura’s bacterial strain. This collaboration eventually led to the development and commercial production of Ivermectin.
Awards and Recognition:
Their combined efforts culminated not only in the creation of a groundbreaking drug but also in accolades that celebrated their contribution to humankind. In 2015, their discoveries were honored with the Nobel Prize in Physiology or Medicine. The Nobel Assembly at the Karolinska Institute awarded half of the prize to Ōmura and Campbell, recognizing their work in developing a therapy against infections caused by roundworm parasites. Their discovery of Ivermectin and its applications brought about significant reductions in the incidence of river blindness and lymphatic filariasis, profoundly impacting global health.
Their legacy stands as a reminder of the transformative impact of scientific collaboration and exploration. Ivermectin, as a result of their combined endeavors, has and continues to bring relief to millions of individuals plagued by debilitating diseases worldwide.
VLA COMMENT: GREAT READ!
The field of pharmacogenomics and pharmacogenetics provides a promising science base for vaccineresearch and development. A broad range of phenotype/genotype data combined with high through put genetic sequencing and bioinformatics are increasingly being integrated into this emerging field of vaccinomics. This paper discusses the hypothesis of the ‘immune response gene network’ and genetic (and bioinformatic) strategies to study associations between immune response gene polymorphisms and variations in humoral and cellular immune responses to prophylactic viral vaccines, such as measles–mumps–rubella, influenza, HIV, hepatitis B and smallpox. Immunogenetic studies reveal promising new vaccine targets by providing a better understanding of the mechanisms by which gene polymorphisms may influence innate and adaptive immune responses to vaccines, including vaccine failure and vaccine-associated adverse events. Additional benefits from vaccinomic studies include the development of personalized vaccines, the development of novel vaccines and the development of novel vaccine adjuvants.
pharmacogenomics_to_vacci-1 MAYO CLINIC STUDY
One month after the conclusion of treatment, a dermatologist reevaluated the patients. Response to treatment was defined as disappearance of all warts without residual scarring. All patients were followed for recurrence for 6 months after the completion of the treatment. P < .05 was considered statistically significant.
The authors of a new review of the drug acetaminophen (paracetamol), sold under the brand names Tylenol and Panadol, called for the immediate end of the use of the drug in infants and children, citing the drug’s association with autism spectrum disorder (ASD).
“Our study shows that acetaminophen would never be approved for pediatric use by today’s regulatory standards,” Dr. William Parker, of WPLab, Inc., who led the research team that conducted the review on acetaminophen and autism, told The Defender.
EXCERPT: Many common over-the-counter drugs contain anticholinergic ingredients, including antihistamine medications sold under the brand names Benadryl and Chlor-Trimeton, sleep aids such as Tylenol PM, Aleve PM and Unisom, the motion sickness medication Dramamine and various cold medicines. READ MORE…
A June 2019 study in JAMA that assessed the dementia risk associated with various anticholinergic drugs found the link was strongest for:
Antidepressants (tricyclic antidepressants such as imipramine, doxepine or amitriptyline have strong anticholinergic effects, whereas SSRIs such as citalopram and duloxetine have lower anticholinergic effects)
Antipsychotics (such as clozapine, chlorpromazine or olanzapine)
Bladder antimuscarinics (such as oxybutynin or tolterodine, prescribed for overactive bladder)
Antiepileptic drugs (such as oxcarbazepine or carbamazepine)
Why isn’t Jesus mentioned in the any of the records of the Historical day?
Why is the only record of Jesus found in the New Testaments decades later?
VLA COMMENT: Don’t be afraid to listen to Archary S. and to embrace multiple perspectives and still maintain a peace that surpasses understanding.
VLA Comment: Editor, Dr. Robert Price is one of our greatest Christian Scholars
See the archives of Aeon Byte Radio